Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06209138Completed
Randomised trial of fluorouracil in Vitiligo (2 arms), sponsored by Al-Azhar University. Primary endpoints: Quartile grading scale at 2 months and JAK3 expression in vitiligo lesions at 2 months. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06209138.